| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue |
-
|
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
|
-
| | | Operating Expenses | | Research Development | 81 | 362 | 1,098 | 1,727 | | Selling General and Administrative | 303 | 334 | 700 | 1,093 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (385) | (696) | (1,798) | (2,821) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1 | 1 | 6 | 19 | | Earnings Before Interest And Taxes | (384) | (695) | (1,793) | (2,802) | | Interest Expense | 2 | 1 | 1 | 1 | | Income Before Tax | (386) | (696) | (1,794) | (2,803) | | Income Tax Expense |
-
|
-
| (1,140) |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (386) | (696) | (654) | (2,803) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (386) | (696) | (654) | (2,803) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($386) | ($696) | ($654) | ($2,803) |
|
0.47% Nasdaq 0.00%
Income Statement
